AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer

NCT00410904 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer

Interventions

DRUG: cediranib maleate
DRUG: pemetrexed disodium

Sponsor

National Cancer Institute (NCI)